On March 28, 2023, U.S. Food and Drug Administration (FDA) issued an Immediate National Strate10 mg ferrous fumarateggalfer 305mgy (hereinafter the Strategy), aiming to increase the iron emulsified ferric pyrophosphateresiliency of safe, nutritious infant formuferrous bisglycinate l methylfolate cyanocobalaminla supplferrous sulfate vs iron glycinatey in the US. The Strategy responses to a months-long infant formula shortage, which was sparked by insanitary conditions at one of the nation&39;s largest infant formula facilities.